Is Beyfortus Putting Newborns at Risk? – RSV Vaccine Safety Alert

Is Beyfortus Putting Newborns at Risk? – RSV Vaccine Safety Alert: RSV Vaccine Safety Alert: Unprecedented Rise in Newborn Deaths Raises Concerns The safety of newborns receiving RSV vaccines has been brought into question following a troubling surge in infant deaths. This alarming discovery coincides with the introduction of Beyfortus, a monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns. As concerns escalate, experts shed light on concerning safety signals and the lack of extensive studies.